News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Rebecca Leaman

Rebecca Leaman is a masters candidate in Global Affairs from New York University.

Articles by Rebecca Leaman

Feeling Lucky? Convergence Mental Health as a Mechanism for Serendipitous Innovation

ByErin Smith,Jessica Carson,Rebecca Leaman,William Hynes, DPhil,Helen Lavretsky, MD, MS,Michael Berk, MD, PhD,Harris A. Eyre, MD, PhD

March 23rd 2021

This mindset might be the key to mental health breakthroughs.

Latest Updated Articles

Trending on Psychiatric Times

Novel PDA10A Inhibitor for Schizophrenia in Development, Discussion With Maciej Wieczorek, MD

Whatever Happened to Psychopathology?

Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD

How Can Chatbots Be Made Safe for Psychiatric Patients

The Dangers of Conversion Therapy: What Chiles v Salazar Could Mean for LGBTQ+ Youth

© 2025 MJH Life Sciences^®

All rights reserved.